Role of endothelin-1 in acute myocardial infarction

Chest

Volumn 127, Issue 5, 2005, Pages 1474-1476

  Khan, Ijaz A ^a,b  

^a University of Maryland School of Medicine ^*

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ACUTE HEART INFARCTION; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; DOSE RESPONSE; DRUG MECHANISM; EDITORIAL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HUMAN; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ST SEGMENT ELEVATION; VASOCONSTRICTION; VASODILATATION; BLOOD; HEART INFARCTION; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS;

ENDOTHELIN-1; HUMANS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VASOCONSTRICTION;

EID: 19844368089     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.5.1474     Document Type: Editorial

References (20)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415
2. Berger R, Pacher R. The role of the endothelin system in myocardial infarction: new therapeutic targets. Eur Heart J 2003; 24:294-296
3. Lavallee M, Thorin E. Role of ET-1 in the regulation of coronary circulation. Can J Physiol Pharmacol 2003; 81:570-577
4. Pernow J, Ahlborg G, Lundberg JM, et al. Long-lasting coronary vasoconstrictor effects and myocardial uptake of endothelin-1 in humans. Acta Physiol Scand 1997; 159:147-153
5. MacCarthy PA, Grocott-Mason R, Prendergast BD, et al. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation 2000; 101:142-147
6. Zolk O, Bohm M. The role of the cardiac endothelin system in heart failure. Nephrol Dial Transplant 2000; 15:758-760
7. Beyer ME, Slesak G, Hovelborn T, et al. Inotropic effects of endothelin-1: interaction with molsidomine and with BQ 610. Hypertension 1999; 33:145-152
8. Stewart DJ, Kubac G, Costello KB, et al. Increased plasma endothelin-1 in the early hours of acute myocardial infarction. Am Coll Cardiol 1991; 18:38-43
9. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 1989; 161:562-567
10. Watanabe T, Suzuki N, Shimamoto N, et al. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991; 69:370-77
11. Tomoda H. Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 1993; 125:667-672
12. Kinlay S, Behrendt D, Wainstein M, et al. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation 2001; 104:1114-1118
13. Krause SM, Lynch JJ Jr, Stabilito II, et al. Intravenous administration of the endothelin-1 antagonist B Q-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog. Cardiovasc Res 1994; 28:1672-1678
14. Mertz TE, McClanahan TB, Flynn MA, et al. Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs. J Pharmacol Exp Ther 1996; 278:42-49
15. McClanahan TB, Mertz TE, Ignasiak DP, et al. Effects of endothelin-receptor antagonism with PD156707 on myocardial stunning in swine. J Cardiovasc Pharmacol 1996; 28:679-686
16. Vitola JV, Forman MB, Holsinger JP, et al. Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists. J Cardiovasc Pharmacol 1996; 28:774-783
17. Beyer ME, Fischer M, Hovelborn T, et al. ET(A) receptor blockade improves post-ischaemic functional recovery in hibernating rat myocardium. Clin Sci 2002; 103 (suppl):215S-218S
18. Krause SM, Clayton FC, Williams DL. Myocardial protection with the non-selective endothelin receptor antagonist L-743,037 following acute coronary artery occlusion in the dog. J Cardiovasc Pharmacol 2004; 43:214-221
19. Tsutamoto T, Wada A, Hayashi M, et al. Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction. Eur Heart J 2003; 24:346-355
20. Omland T, Lie RT, Aakvaag A, et al. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994; 89:1573-1579 1477-1480